Tuberculosis

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 20

Tuberculosis

Michael Boyle

Epidemiology
One of the worlds deadliest diseases
1/3 of world infected
Worldwide (2014)
Incidence: 9.6 million
Mortality: 1.5 million

United States (2014)


Incidence: 9,421
Mortality is 1 to 2 per 100,000

Rates low in developed countries


highly susceptible: HIV-infected, Homeless, Malnourished, Immigrants
Leading killer of HIV infected

Africans, Native Americans and Eskimos are more susceptible than Caucasians
Most common among the elderly

Mycobacterium species, along with


members of a related genus
Nocardia, are classified as:
Coagulase-positive bacteria
Collagenase-positive bacteria
Acid-fast bacteria
Phospholipase-positive bacteria

Etiology
Mycobacterium tuberculosis:
Acid fast, Gram +, obligate
aerobic, non-motile, rod, strict
pathogen
M. tuberculosis bovis,
nonpasteurized milk

In addition to peptidoglycan, the acid-fast cell wall of Mycobacterium


contains a large amount of glycolipids, especially ______ that make
up approximately 60% of acid-fast cell wall.

Beta-lactamases
LPS
Teichoic acids
Mycolic acids

Pathogenesis
Aerosolized droplets: coughing, sneezing and talking
Inhaled
Deposited in alveoli
Lower segments of the lower and middle lobes
anterior segments of the upper lobes

Phagocytosed by alveolar macrophages but resist killing


Mycolic acid blocks fusion of phagosomes and lysosomes and
allows proliferation within macrophages

Carried from the lung to regional (hilar and mediastinal)


lymph nodes
Disseminated by the bloodstream
Continued proliferate at the primary site in the lungs
and elsewhere, including lymph nodes, kidneys,
meninges, epiphyseal plates of long bones and
vertebrae and apical areas of the lungs

Signs and symptoms


Classic clinical features:

Cough
Weight loss/anorexia
Fever
Night sweats
Hemoptysis
Chest pain
Fatigue

Signs and symptoms


Course depends on age, immune competence, total
burden of organisms
Indolent, asymptomatic infection
Destructive, disseminated disease

Infection vs active tuberculosis


More Pts infected than develop clinical symptoms
Infection: organism is growing in a person, whether or not
symptomatic disease
Active: destructive, symptomatic disease

Signs and symptoms


Primary tuberculosis
1st exposure to organism
Either an indolent or aggressive course
Progressive primary tuberculosis develops in less than 10% of
infected normal adults, but more frequently in children and
immunosuppressed patients

Secondary (cavitary) tuberculosis

develops long after a primary infection


results from reactivation of dormant endogenous bacilli
or exposure to exogenous organisms
Always an active disease
or reinfection with exogenous bacilli

Miliary tuberculosis is caused by dissemination of


tubercle bacilli to produce numerous, minute, yellowwhite lesions (resembling millet seeds) in distant organs

Signs and symptoms


Ghon focus (tubercle):
lung lesion of primary tuberculosis
found in the subpleural area of the upper segments of the lower lobes or in the
lower segments of the upper lobes
Initially, small, ill-defined area of inflammatory consolidation, which then drains to
hilar lymph nodes

Ghon complex: combination of peripheral Ghon focus and involved


mediastinal or hilar lymph nodes
Caseous granuloma:
Microscopically, classic lesion of tuberculosis
When number of bacteria is high
Soft, semisolid core surrounded by epithelioid macrophages, Langhans giant cells,
lymphocytes and peripheral fibrous tissue

Tuberculous granuloma with


central caseation
Primary
tuberculosis
Hilar lymph node

Differential diagnosis
Acid fast stain: most commonly used in examining sputum for
mycobacterium tuberculosis
It is a method of staining used in bacteriology in which a smear on a slide is
flooded with carbol fuchsin stain, decolorized with acid alcohol, and
counterstained with methylene blue
Acid-fast organisms resist decolorization and appear red against a blue background
under a microscope
This property of being acid-fast is attributable to the presence of lipids and waxes
(mycolic acids) in the cell wall of certain bacteria

Differential diagnosis
PPD skin test: is the classic skin
test for tuberculosis
PPD may indicate an infection but
not whether an infection is active
Purified protein derivative (PPD)
extracted from the mycobacterium
tuberculosis is injected
subcutaneously
The area near the injection is
observed for a delayed
hypersensitivity reaction (necrosis)
A positive test indicates a
hypersensitivity to tuberculoproteins

Differential diagnosis
Well known for its ability to masquerade as other
infectious and disease processes.
The following may resemble pulmonary TB include :
Blastomycosis
Tularemia
Actinomycosis
Mycobacterium avium-intracellulare infection
M chelonae infection
M fortuitum infection
M gordonae infection
M kansasii infection
M marinum infection
M xenopi infection
Squamous cell carcinoma

Conditions to be included in the differential diagnosis


of extrapulmonary TB include the following:
Blastomycosis
Tularemia
Actinomycosis
Hidradenitis suppurativa
Eosinophilic granuloma
M avium-intracellulareinfection
M chelonaeinfection
M fortuituminfection
M gordonaeinfection
M kansasiiinfection
M marinuminfection
M xenopiinfection
Endemic syphilis
Erythema induratum (nodular vasculitis)
Erythema nodosum
Leishmaniasis
Leprosy
Cat scratch disease
Syphilis
Syringoma
Rheumatoid arthritis

Diagnosis of skin infection withM


tuberculosisinvolves the following:
Differentiate primary-inoculation TB from ulceroglandular complexes and mycobacterioses
Differentiate TB verrucosa cutis from diseases such as North American blastomycosis,
chromoblastomycosis, iododerma and bromoderma, chronic vegetative pyoderma, verruca
vulgaris, verrucous carcinoma, verrucous atypical mycobacterial infection, and verrucous lupus
vulgaris
Differentiate miliary TB of the skin (which appears as small, noncharacteristic, erythematous,
papular or purpuric lesions) from drug reactions
Differentiate scrofuloderma from suppurative lymphadenitis with sinus-tract formation, such as
blastomycosis or coccidioidomycosis
Differentiate TB cutis orificialis from glossitis, apotheosis, and deep fungal infections
Differentiate lupus vulgaris from lupoid rosacea, deep fungal or atypical mycobacterial infection,
chronic granulomatous disease, granulomatous rosacea, and Wegener granulomatosis
Differentiate erythema induratum from nodular panniculitides (eg, Weber-Christian disease) and
nodular vasculitides (eg, syphilitic gumma, nodular pernio)
Differentiate papulonecrotic tuberculid from other papulonecrotic entities, such as
leukocytoclastic vasculitis, lymphomatoid papulosis, papular eczema, and prurigo simplex with
neurotic excoriation
Differentiate lichen scrofulosorum from keratosis spinulosa, lichenoid sarcoid, and lichenoid
secondary syphilis

Treatment
Latent TB
isoniazid (INH)
rifampin (RIF)
rifapentine (RPT)

TB disease (Active TB)

isoniazid (INH)
rifampin (RIF)
ethambutol (EMB)
pyrazinamide (PZA)

Initial phase: 2 months


Continuation phase: 4-7 months

Prognosis
Full resolution is generally expected with few
complications in cases of non-drug resistant TB, when the
drug regimen is completed
Recurrence: 0-14%
Poor prognostic markers: extrapulmonary involvement, an
immunocompromised state, older age, and a history of
previous treatment
Risk factors for dying: reduced baseline TNF- response
to stimulation (with heat-killedM. tuberculosis), low body
mass index, and elevated respiratory rate at TB diagnosis

Summary
Epidemiology: HIV-infected, homeless, malnourished, immigrants
Etiology: M. tuberculosis, acid fast, Gram +, obligate aerobic, non-motile, rod,
strict pathogen
Pathogenesis: Aerosolized droplets, Inhaled
Lungsmacrophageslymph nodes
Miliary TB: disseminated
Mycolic acid

Signs and symptoms: Cough, anorexia, fever, night sweats, hemoptysis, chest
pain, fatigue
Ghon focus, Ghon complex, caseous granuloma

Differential diagnosis: Acid fast stain (carbol fuchsin), PPD test


Treatment: rifampin, isoniazid, pyrazinamide, ethambutol
Prognosis: Good with drug regimen, recurrence

References
Murray, Patrick, Ken Rosenthal, Michael Pfaller. Medical
Microbiology, 7th Edition. W.B. Saunders Company,
2013.
Rubin. Rubin's Pathology: Clinicopathologic Foundations
of Medicine, 6th Edition. Lippincott Williams & Wilkins.
http://www.cdc.gov/tb/

You might also like